- Home
- ERAS vs SHYF Comparison
ERAS vs SHYF Comparison
Compare ERAS & SHYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- SHYF
- Stock Information
- Founded
- ERAS 2018
- SHYF 1975
- Country
- ERAS United States
- SHYF United States
- Employees
- ERAS N/A
- SHYF N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- SHYF Auto Manufacturing
- Sector
- ERAS Health Care
- SHYF Consumer Discretionary
- Exchange
- ERAS Nasdaq
- SHYF Nasdaq
- Market Cap
- ERAS 396.6M
- SHYF 428.3M
- IPO Year
- ERAS 2021
- SHYF N/A
- Fundamental
- Price
- ERAS $1.43
- SHYF $9.33
- Analyst Decision
- ERAS Strong Buy
- SHYF Strong Buy
- Analyst Count
- ERAS 6
- SHYF 2
- Target Price
- ERAS $4.83
- SHYF $15.50
- AVG Volume (30 Days)
- ERAS 1.5M
- SHYF 289.5K
- Earning Date
- ERAS 05-20-2025
- SHYF 04-24-2025
- Dividend Yield
- ERAS N/A
- SHYF 2.17%
- EPS Growth
- ERAS N/A
- SHYF 744.40
- EPS
- ERAS N/A
- SHYF 0.01
- Revenue
- ERAS N/A
- SHYF $792,886,000.00
- Revenue This Year
- ERAS N/A
- SHYF $15.03
- Revenue Next Year
- ERAS N/A
- SHYF $8.68
- P/E Ratio
- ERAS N/A
- SHYF $727.54
- Revenue Growth
- ERAS N/A
- SHYF N/A
- 52 Week Low
- ERAS $1.01
- SHYF $6.82
- 52 Week High
- ERAS $3.45
- SHYF $17.56
- Technical
- Relative Strength Index (RSI)
- ERAS 52.92
- SHYF 58.80
- Support Level
- ERAS $1.37
- SHYF $8.66
- Resistance Level
- ERAS $1.61
- SHYF $9.41
- Average True Range (ATR)
- ERAS 0.14
- SHYF 0.53
- MACD
- ERAS 0.00
- SHYF 0.16
- Stochastic Oscillator
- ERAS 53.09
- SHYF 96.14
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About SHYF The Shyft Group Inc.
The Shyft Group Inc is engaged in specialty vehicle manufacturing and assembly for commercial vehicles (including last-mile delivery, specialty service, and vocation-specific upfit segments) and recreational vehicle industries. Its products include walk-in vans, truck bodies, cargo vans, and pick-up truck upfits used in e-commerce/parcel delivery, upfit equipment used in the mobile retail and utility trades, as well as luxury Class A diesel motorhome custom chassis and contract manufacturing and assembly services. It also supplies replacement parts and offers repair, maintenance, field service, and refurbishment services for the vehicles that the company manufactures.